Skip to main content

Brand exposure and tech front of mind for Avantia as it secures fresh PE backing

Mark-Eastham

Avantia has secured further investment from private equity backers ECI, which it will use to expand the capabilities and applications of its machine learning technology and boost the profile of its Homeprotect brand.

Mark Eastham, pictured, Avantia CEO, told Post that the managing general agent would invest in above-the-line advertising to help Homeprotect stand out against its competitors on price comparison

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Admiral sticks with gender-neutral toilets

Admiral has come under fire for continuing to have gender-neutral toilets while it awaits updated guidance from the Equality and Human Rights Commission after last year’s Supreme Court ruling on biological sex.

Hantavirus outbreak raises complex insurance questions

The hantavirus outbreak onboard MV Hondius has exposed the legal, operational and insurance challenges facing cruise operators when infectious disease incidents escalate across multiple jurisdictions, according to Alexandra Pearson, member of the travel sector focus team of the Forum of Insurance Lawyers.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here